|
Market Closed -
BME
11:36:19 2026-09-21 am EDT
|
5-day change | 1st Jan Change | ||
| 58.85 EUR | +2.08% |
|
+2.71% | -7.32% |
| Jul. 23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| Jul. 23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.08% | +2.71% | -1.59% | +1.47% | -7.32% | -0.51% | +13.83% | +4.16% | +334.00% | 3.38B | |
| +1.04% | +2.34% | -7.21% | +6.04% | +8.39% | +54.91% | +111.75% | +406.10% | +1,340.45% | 1,028B | |
| -0.19% | +1.18% | -0.28% | +17.99% | +30.21% | +52.94% | +66.69% | +63.78% | +126.62% | 651B | |
| +0.20% | +1.04% | -0.18% | +22.17% | +15.75% | +18.88% | +72.38% | +146.83% | +312.61% | 466B | |
| +2.24% | +0.94% | -2.88% | +14.07% | +11.15% | +37.61% | +45.31% | +7.50% | +49.75% | 346B | |
| +0.90% | +1.95% | -8.85% | -1.83% | +5.97% | +18.79% | +25.27% | +50.69% | +47.11% | 266B | |
| +0.48% | +3.34% | +2.61% | -5.09% | -8.92% | +11.11% | +15.38% | +44.20% | +147.93% | 259B | |
| +1.95% | +3.06% | -10.51% | +16.46% | +20.12% | +37.75% | +45.93% | +82.56% | +126.15% | 208B | |
| -7.65% | -7.28% | -13.58% | -11.25% | -20.06% | -33.09% | -59.52% | -19.85% | +69.00% | 191B | |
| +0.30% | +2.83% | +3.04% | +21.65% | +22.67% | +31.97% | +100.03% | +109.90% | +84.28% | 186B | |
| +0.29% | +0.07% | -1.18% | +10.04% | +11.41% | +15.44% | -15.56% | -36.84% | -19.08% | 158B | |
| +0.47% | -1.69% | -6.81% | +13.08% | +12.65% | +33.31% | +44.16% | +174.88% | +456.22% | 129B | |
| -0.70% | -2.31% | -6.55% | +15.96% | +16.09% | +39.09% | +5.99% | +3.80% | +11.96% | 129B | |
| +0.73% | -1.11% | -5.51% | +0.61% | -9.83% | -7.30% | -27.23% | -9.29% | +8.59% | 102B | |
| +1.78% | +3.05% | -0.39% | -0.75% | +4.74% | +27.70% | +24.85% | +7.74% | -6.18% | 101B | |
| +0.93% | +5.18% | -3.78% | -10.65% | -18.16% | -1.17% | +58.17% | +63.38% | +461.39% | 70.71B | |
| +0.37% | +4.03% | +3.54% | +20.96% | +23.43% | +33.27% | +25.59% | +58.77% | +25.27% | 60.71B | |
| +1.95% | -0.61% | +2.06% | +29.57% | +32.48% | +78.29% | +2.64% | +7.02% | -46.48% | 54.18B | |
| +2.77% | +3.46% | +8.27% | +32.04% | +40.02% | +179.75% | +290.83% | +356.78% | -22.06% | 45.42B | |
| +4.85% | +6.70% | -3.56% | -4.92% | -22.71% | -33.90% | +4.90% | -1.94% | +184.98% | 43.2B | |
| Average | +0.81% | +1.96% | -2.67% | +9.38% | +8.40% | +29.74% | +42.57% | +76.01% | +184.62% | 224.85B | |
| Weighted average by Cap. | +0.64% | +1.93% | -3.74% | +10.07% | +11.35% | +34.41% | +57.42% | +140.17% | +406.12% |
- Stock Market
- Stocks
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
Select your edition
All financial news and data tailored to specific country editions
